Structural and Mutational Analysis of the Nonribosomal Peptide Synthetase Heterocyclization Domain Provides Insight Into Catalysis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
FMB Ch05-Gerwick.Indd
PB Marine Cyanobacteria Ramaswamy et al. 175 5 The Secondary Metabolites and Biosynthetic Gene Clusters of Marine Cyanobacteria. Applications in Biotechnology Aishwarya V. Ramaswamy, Patricia M. Flatt, Daniel J. Edwards, T. Luke Simmons, Bingnan Han and William H. Gerwick* Abstract Marine cyanobacteria have proven to be one of the most versatile marine producers of secondary metabolites. Many of these metabolites demonstrate antiproliferative activity (e.g. curacin A, dolastatins), acute cytotoxic activity (e.g. apratoxin, hectochlorin) or have specific neurotoxic activity (e.g. kalkitoxin, antillatoxin), making them invaluable as potential therapeutic leads or pharmacological tools. The predominant biogenetic theme in cyanobacterial natural products chemistry is the integration of polyketide synthases (PKS) and nonribosomal peptide synthetases (NRPS) along with a variety of unusual tailoring or modifying enzymes, and accounts for the tremendous structural diversity of their metabolites. Only recently has the genetic architecture of several cyanobacterial biosynthetic gene clusters been determined, and studies to understand and exploit this biosynthentic machinery present an exciting new frontier. This chapter will summarize the properties of several notable metabolites from marine cyanobacteria that have clinical or pharmacological applications followed by a detailed account of their biosyntheses at the molecular genetic level and their potential applications in biotechnology. 1. Introduction Cyanobacteria, also known as blue-green algae, are ancient (ca. 2 x 109 years) photosynthetic prokaryotes which inhabit a wide diversity of habitats including *For correspondence email [email protected] 176 Marine Cyanobacteria Ramaswamy et al. 177 open oceans, tropical reefs, shallow water environments, terrestrial substrates, aerial environments such as in trees and rock faces, and fresh water ponds, streams and puddles (Whitton and Potts, 2000) . -
Patellamide a and C Biosynthesis by a Microcin-Like Pathway in Prochloron Didemni, the Cyanobacterial Symbiont of Lissoclinum Patella
Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella Eric W. Schmidt*†, James T. Nelson*, David A. Rasko‡, Sebastian Sudek§, Jonathan A. Eisen‡, Margo G. Haygood§, and Jacques Ravel‡ *Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT 84112; ‡The Institute for Genomic Research, Rockville, MD 20850; and §Scripps Institution of Oceanography, University of California at San Diego, La Jolla, CA 92093 Edited by Robert Haselkorn, University of Chicago, Chicago, IL, and approved April 7, 2005 (received for review February 18, 2005) Prochloron spp. are obligate cyanobacterial symbionts of many a project to sequence the genome of Prochloron didemni, isolated didemnid family ascidians. It has been proposed that the cyclic from the ascidian Lissoclinum patella. peptides of the patellamide class found in didemnid extracts are The patellamides and trunkamide (another didemnid product) synthesized by Prochloron spp., but studies in which host and are peptides that exemplify both the unique structural features and symbiont cells are separated and chemically analyzed to identify potent bioactivities of didemnid ascidian natural products (Fig. 1). the biosynthetic source have yielded inconclusive results. As part Both groups have clinical potential, because patellamides are of the Prochloron didemni sequencing project, we identified pa- typically moderately cytotoxic, and patellamides B, C, and D tellamide biosynthetic genes and confirmed their function by reportedly reverse multidrug resistance (15, 16), whereas trunka- heterologous expression of the whole pathway in Escherichia coli. mide was initially isolated because of specific and unusual activity The primary sequence of patellamides A and C is encoded on a against the multidrug-resistant UO-31 renal cell line (17). -
Development of Novel Imaging System by Using Firefly Bioluminescence
A Thesis for the Degree of Ph.D. (Science) Development of novel imaging system by using firefly bioluminescence March 2017 Graduate School of Science and Technology Keio University Shuji Ioka Contents Chapter 1. Introduction 1 1-1. Chemistry of bioluminescence 2 1-2. Firefly bioluminescence 6 1-3. Applications of firefly bioluminescence 8 1-4. Structure activity relationship of firefly luciferin 12 Chapter 2. Synthesis of firefly luciferin analogues and evaluation of the luminescent properties 15 2-1. Introduction 16 2-2. Results and discussion 2-2-1. Synthesis of firefly luciferin analogues 18 2-2-2. Bioluminescence 22 2-2-3. Chemiluminescence 26 2-2-4. Inhibitory activity of bioluminescence 28 2-2-5. Adenylation of synthetic compound 30 2-2-6. Bioluminescence in vivo 33 2-3. Summary 35 Chapter 3. Development of a luminescence-controllable firefly luciferin analogue using selective enzymatic cyclization 37 3-1. Introduction 38 3-2. Results and discussion 3-2-1. Synthesis of N-Ac-γ-glutamate luciferin 40 3-2-2. Cyclization with aminoacylase 41 3-2-3. Reaction rate of cyclization 43 3-2-4. Bioluminescence with aminoacylase 45 3-3. Summary 48 Chapter 4. Conclusion 49 Experimental Section 53 References 81 Acknowledgements 87 Abbreviations Ac acetyl Ala alanine AMP adenosine monophosphate aq aqueous ATP adenosine triphosphate BFP blue fluorescent protein BRET bioluminescence resonance energy transfer Boc tert-butoxycarbonyl Bu butyl BL bioluminescence Co. cooperation DAL diaminophenylpropyl-aminoluciferin DAST diethylaminosulfur trifluoride DCC dicyclohexylcarbodiimide DMAP N,N-dimethyl-4-aminopyridine DMF N,N-dimethylformamide DMSO dimethyl sulfoxide ESI electrospray ionization Et ethyl ffLuc fluorescent protein fused luciferase GFP green fluorescent protein Gly glycine HPLC high performance liquid chromatography isoAm isoamyl Imd. -
The Structural Biology of Patellamide Biosynthesis
Available online at www.sciencedirect.com ScienceDirect The structural biology of patellamide biosynthesis 1 1 2,3 Jesko Koehnke , Andrew F Bent , Wael E Houssen , 1 2 1 Greg Mann , Marcel Jaspars and James H Naismith The biosynthetic pathways for patellamide and related natural the pharmaceutical armory for treating diseases ranging products have recently been studied by structural biology. from bacterial infection to cancer to immune suppression These pathways produce molecules that have a complex [4]. Synthetic biology promises, amongst other deliver- framework and exhibit a diverse array of activity due to the ables, the ability to tailor enzymes in biosynthetic pathways variability of the amino acids that are found in them. As these to create natural product variants with desirable properties molecules are difficult to synthesize chemically, exploitation of in the quantities required for drug development [5]. their properties has been modest. The patellamide pathway involves amino acid heterocyclization, peptide cleavage, Peptide based natural products are particularly attractive peptide macrocyclization, heterocycle oxidation and from a chemical point of view; amino acids share a common epimerization; closely related products are also prenylated. standard in connectivity (the amide bond) with an almost Enzyme activities have been identified for all these infinitely configurable element (the side chain). One can transformations except epimerization, which may be thus ‘dial’ in chemical and structural properties into a spontaneous. This review highlights the recent structural and shared basic design. Crucially, in the same way as no mechanistic work on amino acid heterocyclization, peptide two proteins need to share any biological property, pep- cleavage and peptide macrocyclization. -
Natural Bioactive Thiazole-Based Peptides from Marine Resources: Structural and Pharmacological Aspects
marine drugs Review Natural Bioactive Thiazole-Based Peptides from Marine Resources: Structural and Pharmacological Aspects 1, , 2, , 3 4 Rajiv Dahiya * y , Sunita Dahiya * y, Neeraj Kumar Fuloria , Suresh Kumar , Rita Mourya 5, Suresh V. Chennupati 6, Satish Jankie 1, Hemendra Gautam 7, Sunil Singh 8, Sanjay Kumar Karan 9, Sandeep Maharaj 1, Shivkanya Fuloria 3, Jyoti Shrivastava 10, Alka Agarwal 11, Shamjeet Singh 1, Awadh Kishor 12, Gunjan Jadon 13 and Ajay Sharma 14 1 School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad & Tobago; [email protected] (S.J.); [email protected] (S.M.); [email protected] (S.S.) 2 Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, PR 00936, USA 3 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, AIMST University, Semeling, Bedong 08100, Kedah, Malaysia; [email protected] (N.K.F.); [email protected] (S.F.) 4 Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra 136119, Haryana, India; sureshmpharma@rediffmail.com 5 School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar 6200, Ethiopia; [email protected] 6 Department of Pharmacy, College of Medical and Health Sciences, Wollega University, P.O. Box 395, Nekemte, Ethiopia; sureshchennupati@rediffmail.com 7 Arya College of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University, Nawabganj, Bareilly 243407, Uttar -
The Structural Biology of Patellamide Biosynthesis
Available online at www.sciencedirect.com ScienceDirect The structural biology of patellamide biosynthesis 1 1 2,3 Jesko Koehnke , Andrew F Bent , Wael E Houssen , 1 2 1 Greg Mann , Marcel Jaspars and James H Naismith The biosynthetic pathways for patellamide and related natural the pharmaceutical armory for treating diseases ranging products have recently been studied by structural biology. from bacterial infection to cancer to immune suppression These pathways produce molecules that have a complex [4]. Synthetic biology promises, amongst other deliver- framework and exhibit a diverse array of activity due to the ables, the ability to tailor enzymes in biosynthetic pathways variability of the amino acids that are found in them. As these to create natural product variants with desirable properties molecules are difficult to synthesize chemically, exploitation of in the quantities required for drug development [5]. their properties has been modest. The patellamide pathway involves amino acid heterocyclization, peptide cleavage, Peptide based natural products are particularly attractive peptide macrocyclization, heterocycle oxidation and from a chemical point of view; amino acids share a common epimerization; closely related products are also prenylated. standard in connectivity (the amide bond) with an almost Enzyme activities have been identified for all these infinitely configurable element (the side chain). One can transformations except epimerization, which may be thus ‘dial’ in chemical and structural properties into a spontaneous. This review highlights the recent structural and shared basic design. Crucially, in the same way as no mechanistic work on amino acid heterocyclization, peptide two proteins need to share any biological property, pep- cleavage and peptide macrocyclization.